FDA approves Adempas to treat pulmonary hypertension FDA.gov In its various forms, pulmonary hypertension is a chronic, progressive, debilitating disease, often leading to death or need for lung transplantation. Adempas belongs to a class of drugs called soluble guanylate cyclase stimulators that help arteries ... |
